FDA Inspection 1165814 — Versiti Illinois, Inc.
The FDA completed an inspection of Versiti Illinois, Inc. on Mar 22, 2022 in Elgin, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 22, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Elgin, IL (United States)